| A review of neuroprotection pharmacology and therapies in patients with acute traumatic brain injury KW McConeghy, J Hatton, L Hughes, AM Cook CNS drugs 26, 613-636, 2012 | 193 | 2012 |
| Vancomycin administration into the cerebrospinal fluid: a review MS Luer, J Hatton Annals of Pharmacotherapy 27 (7-8), 912-921, 1993 | 141 | 1993 |
| Intracerebroventricular administration of drugs AM Cook, KD Mieure, RD Owen, AB Pesaturo, J Hatton Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 29 (7 …, 2009 | 139 | 2009 |
| Augmented renal clearance AM Cook, J Hatton‐Kolpek Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 39 (3 …, 2019 | 131 | 2019 |
| Dosing and safety of cyclosporine in patients with severe brain injury J Hatton, B Rosbolt, P Empey, R Kryscio, B Young Journal of neurosurgery 109 (4), 699-707, 2008 | 121 | 2008 |
| Intravenous insulin-like growth factor-I (IGF-I) in moderate-to-severe head injury: a phase II safety and efficacy trial J Hatton, RP Rapp, KA Kudsk, RO Brown, MS Luer, JG Bukar, SA Chen, ... Journal of neurosurgery 86 (5), 779-786, 1997 | 103 | 1997 |
| Postpyloric enteral feeding costs for patients with severe head injury: blind placement, endoscopy, and PEG/J versus TPN L OTT, KIM Annis, J HATTON, M McCLAIN, B YOUNG Journal of neurotrauma 16 (3), 233-242, 1999 | 81 | 1999 |
| Pharmacological treatment of traumatic brain injury: a review of agents in development J Hatton CNS drugs 15, 553-581, 2001 | 73 | 2001 |
| The risks of polypharmacy following spinal cord injury P Kitzman, D Cecil, JH Kolpek The journal of spinal cord medicine 40 (2), 147-153, 2017 | 68 | 2017 |
| Cyclosporin A disposition following acute traumatic brain injury PE Empey, PJ McNamara, B Young, MB Rosbolt, J Hatton Journal of neurotrauma 23 (1), 109-116, 2006 | 60 | 2006 |
| Comparison of urinary urea nitrogen excretion and measured energy expenditure in spinal cord injury and Nansteroid‐treated severe head trauma patients JH Kolpek, LG Ott, KE Record, RP Rapp, R Dempsey, P Tibbs, B Young Journal of Parenteral and Enteral Nutrition 13 (3), 277-280, 1989 | 60 | 1989 |
| Systemic metabolic effects of combined insulin-like growth factor–I and growth hormone therapy in patients who have sustained acute traumatic brain injury J Hatton, R Kryscio, M Ryan, L Ott, B Young Journal of neurosurgery 105 (6), 843-852, 2006 | 53 | 2006 |
| A step-wise protocol for stress ulcer prophylaxis in the neurosurgical intensive care unit J Hatton, WY Lu, DH Rhoney, PA Tibbs, RJ Dempsey, B Young Surgical neurology 46 (5), 493-499, 1996 | 48 | 1996 |
| Cyclosporine A for neuroprotection: establishing dosing guidelines for safe and effective use AM Cook, J Whitlow, J Hatton, B Young Expert Opinion on Drug Safety 8 (4), 411-419, 2009 | 43 | 2009 |
| Successful enteral nutritional support in the neurocritical care unit SD Zarbock, D Steinke, J Hatton, B Magnuson, KM Smith, AM Cook Neurocritical care 9, 210-216, 2008 | 43 | 2008 |
| New pharmacologic strategies for acute neuronal injury MS Luer, DH Rhoney, M Hughes, J Hatton Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 16 (5 …, 1996 | 42 | 1996 |
| New pharmacologic approaches to acute spinal cord injury DH Rhoney, MS Luer, M Hughes, J Hatton Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 16 (3 …, 1996 | 41 | 1996 |
| Management of bacterial urinary tract infections in adults J Hatton, M Hughes, CH Raymond Annals of Pharmacotherapy 28 (11), 1264-1272, 1994 | 36 | 1994 |
| ICU recovery clinic attendance, attrition, and patient outcomes: the impact of severity of illness, gender, and rurality KP Mayer, H Boustany, EP Cassity, MK Soper, AG Kalema, JH Kolpek, ... Critical Care Explorations 2 (10), e0206, 2020 | 34 | 2020 |
| How to minimize interaction between phenytoin and enteral feedings: two approaches S Gilbert, J Hatton, B Magnuson Nutrition in clinical practice 11 (1), 28-31, 1996 | 31 | 1996 |
